2013
DOI: 10.1038/ja.2013.93
|View full text |Cite|
|
Sign up to set email alerts
|

In vitro antitrypanosomal activity of the cyclodepsipeptides, cardinalisamides A–C, from the insect pathogenic fungus Cordyceps cardinalis NBRC 103832

Abstract: During the search for new antitrypanosomal drug leads, three new antitrypanosomal compounds, cardinalisamides A-C (1-3), were isolated from cultures of the insect pathogenic fungus Cordyceps cardinalis NBRC 103832. Their structures were elucidated using MS analyses and extensive 2D-heteronuclear NMR. The absolute configurations of 1-3 were addressed by chemical degradation and Marfey's analysis. 1-3 showed in vitro antitrypanosomal activity against Trypanosoma brucei brucei with IC50 values of 8.56, 8.65 and 8… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 19 publications
0
15
0
Order By: Relevance
“…Compounds 1 and 2 exhibited potent antifungal activities against the plant pathogens C. gloeosporioides and C. musae, and compounds 1 and 3 towards F. oxysporum, yielding better results compared with the positive control carbendazim, thus indicating that these compounds could be potential antifungal agents. To date, cyclic hexadepsipeptides have been reported to possess diverse bioactivities, including antimalaria, antituberculosis, cytotoxic [28], acetylcholinesterase inhibitory [29], antitrypanosomal [30], anti-inflammatory [31], insecticidal [32], antibacterial [33], phtotoxic [34], and immunosuppressive [21] activities. However, only a few cyclic hexadepsipeptides have been reported to possess antifungal activities.…”
Section: Resultsmentioning
confidence: 99%
“…Compounds 1 and 2 exhibited potent antifungal activities against the plant pathogens C. gloeosporioides and C. musae, and compounds 1 and 3 towards F. oxysporum, yielding better results compared with the positive control carbendazim, thus indicating that these compounds could be potential antifungal agents. To date, cyclic hexadepsipeptides have been reported to possess diverse bioactivities, including antimalaria, antituberculosis, cytotoxic [28], acetylcholinesterase inhibitory [29], antitrypanosomal [30], anti-inflammatory [31], insecticidal [32], antibacterial [33], phtotoxic [34], and immunosuppressive [21] activities. However, only a few cyclic hexadepsipeptides have been reported to possess antifungal activities.…”
Section: Resultsmentioning
confidence: 99%
“…Cardinalisamides A–C ( 32 – 34 ) were separated from C. cardinalis NBRC 103832. Cardinalisamides A–C showed antitrypanosomal activity against Trypanosoma brucei and their IC 50 were 8.56, 8.65 and 8.63 mg/mL, respectively, in vitro, and had IC 50 values of 18.48, 14.00 and 23.84 mg/mL, respectively, against normal human diploid fibroblasts (MRC-5 cells) in cytotoxicity assays [ 36 ]. Cordycecin A ( 35 ) and two known compounds beauvericins E ( 36 ) and J ( 37 ) were separated from the ascocarps and insect-body tranches of C. cicadae .…”
Section: Non-ribosomal Peptides and Alkaloidsmentioning
confidence: 99%
“…Fungal depsipeptides have recently been reviewed Molecules 2020, 25, 911 9 of 18 at length [64], therefore, this section will focus on a few selected depsipeptides. Depsipeptides have been isolated from many ascomycete fungi, including plant pathogenic species in the genera Fusarium, Alternaria, Calonectria and Cochliobolus [65] as well as entomopathogenic fungal species, such as Cordyceps cardinalis and Ophiocordyceps communis [66,67]. Many depsipeptides exhibit both antimicrobial and insecticidal activity, and have, therefore, attracted attention for potential use in the development of new drug and crop protection products.…”
Section: Depsipeptidesmentioning
confidence: 99%